Navigation Links
Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
Date:3/19/2013

ects $2.7 million of cash interest expense and $4.2 million of non-cash interest expense. Interest expense for the three-month period ended December 31, 2011 reflects $2.7 million of cash interest expense and $1.8 million of non-cash interest expense.

Other income, net increased $4.5 million to $5.6 million for the three-month period ended December 31, 2012, from $1.1 million for the three-month period ended December 31, 2011.  This increase is primarily due to a non-cash gain of $5.1 million during the three-month period ended December 31, 2012 relating to the mark-to-market valuation adjustment of our warrant liability.

CONFERENCE CALL AND WEBCAST
The Company will host a live conference call and webcast on March 19, 2013, at 9:00 a.m. Eastern Time to discuss these results and to answer questions.  To participate by telephone, please dial:Domestic:

866-393-1565International:

253-237-1151Conference ID:

99134844The live and archived webcast can be accessed via the investor relations section of the Savient website at www.savient.com.  A telephone replay will be available through March 25, 2013, by dialing:

Domestic:

855-859-2056International:

404-537-3406Conference ID:

99134844ABOUT SAVIENT PHARMACEUTICALS, INC.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients who do not respond to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and c
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
2. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
3. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
6. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
7. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
8. AVANIR Pharmaceuticals To participate in two conferences in March
9. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
10. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
11. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. (Nasdaq: ... focused on obtaining FDA clearance and commercializing its rapid, ... the pricing of an underwritten public offering of 10,000,000 ... purchase 3,500,000 shares of its common stock at an ... public offering price of $1.25 per share and related ...
(Date:5/23/2013)... Graphite Metallizing Corporation announces a series ... stainless steel pillow blocks. This series combines the ... application and installation versatility of pillow blocks. , ... exceptionally well when submerged in water, water-soluble chemicals ... acids, alkalies, hydrocarbons, black liquor, and liquid gases. ...
(Date:5/23/2013)... BROWNSBURG, Ind. , May 23, 2013  Rahal ... leader in human cord blood stem cell banking and ... sponsor of the No. 16 Acorn Stairlifts Indy car ... is for the remainder of the IZOD IndyCar 2013 ... Racing (RLL) will work to support awareness of umbilical ...
(Date:5/23/2013)... 2013 VG Energy, an agricultural biotech ... Renewable Research to conduct field trials using LipidMax ... is a majority owned subsidiary of VG Life ... Energy,s exclusively licensed compound LipidMax selectively inhibits certain ... plants, possessing a wide variety of applications including ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... Sept. 15 BioMed Realty Trust, Inc.,(NYSE: BMR ) ... quarter 2008 dividend of $0.335 per share of common stock. ... common share., BioMed also announced that its board of ... company,s 7.375% Series A Cumulative,Redeemable Preferred Stock for the period ...
... (NYSE: SYK ) announced that it will host ... p.m., Eastern Time, to discuss the,Company,s operating results for ... update. Operating results for the quarter ended,September 30, 2008 ... To participate in the conference call dial 800-299-9630 (domestic) ...
... Fougera, a division of Nycomed,US Inc., today announced ... The generic formulation compares to Taro,s Referenced Listed ... tubes (NDC # 0168-0133-15), 30g tubes,(NDC # 0168-0133-30) ... approval of Clotrimazole Cream is another illustration of,Fougera,s ...
Cached Biology Technology:BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends 2Stryker to Host Conference Call on October 16, 2008 2
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
(Date:5/23/2013)... tight wrapping of genomic DNA around nucleosomes in ... expression. A team of Ludwig-Maximilians-Universitaet (LMU) in Munich ... to be locally displaced from nucleosomes for transcription. ... stored in the cell nucleus, wrapped around disk-shaped ... of four different histone proteins and accommodating two ...
(Date:5/23/2013)... the world are billions of animal and plant specimens ... grasses, all stacked, stored and preserved in jars and ... be critical to understanding how the Earth,s biodiversity is ... if only the information were easily accessible. , ... help of a team from the University of Colorado ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Biochemistry: Unspooling DNA from nucleosomal disks 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... in managing digital risk and uncovering digital evidence has helped ... fuel and accelerate the company,s growth. "This investment ... time," says Eric Friedberg , Co-President of Stroz ... to expand to key markets in the U.S., Europe, the ...
... Tech Associate Professor of Mechanical Engineering Rolf Mueller ... China , considered China,s highest honor for "foreign experts who ... progress." Zhang Dejiang, vice-premier of China, made the ... of the People in Beijing. Mueller was also the invited ...
... issue of the Annals of the Missouri Botanical Garden ... family, a group that is related to the sandalwoods ... Hondurodendron , is endemic to Honduras and means "tree ... , a New Monotypic Genus of Aptandraceae from Honduras," ...
Cached Biology News:Stroz Friedberg Amplifying Growth with $115MM New Mountain Capital Investment 2Stroz Friedberg Amplifying Growth with $115MM New Mountain Capital Investment 3Stroz Friedberg Amplifying Growth with $115MM New Mountain Capital Investment 4Virginia Tech's Mueller receives friendship award from China 2Missouri Botanical Garden researcher discover new genus 2Missouri Botanical Garden researcher discover new genus 3
BD BioCoat Laminin 150 mm Culture Dishes...
MAb to Desmoplakin I & II Desmoplakin I & II...
...
BD Primaria 35 mm Cell Culture Dish with Easy-Grip design, surface-modified polystyrene for enhanced cell culture. (20/sp, 200/ca) Packaging: 20 / sleeve, 500 / case ...
Biology Products: